Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-08 Sale | 2026-09-10 3:34 pm | Metagenomi Therapeutics Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,911 | $1.1584 | $2,214 | 206,580 (Direct) | View |
| 2026-06-05 Sale | 2026-06-10 11:23 am | Metagenomi Therapeutics Inc. | MGX | Wapnick Pamela Chief Financial Officer | 2,884 | $1.299 | $3,746 | 208,491 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 5:16 pm | Metagenomi Therapeutics Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,581 | $1.6 | $2,530 | 187,375 (Direct) | View |
| 2025-12-05 Sale | 2025-12-08 1:49 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,576 | $1.7719 | $2,793 | 188,956 (Direct) | View |
| 2025-09-05 Sale | 2025-12-01 7:32 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,576 | $1.81 | $2,853 | 190,532 (Direct) | View |
| 2025-06-06 Sale | 2025-06-09 6:54 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,576 | $1.75 | $2,758 | 72,108 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:36 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,808 | $1.8748 | $3,390 | 59,684 (Direct) | View |
| 2024-12-05 Sale | 2024-12-06 4:24 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,559 | $1.86 | $2,900 | 61,492 (Direct) | View |
| 2024-09-05 Sale | 2024-09-06 5:14 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 6,265 | $2.88 | $18,043 | 63,051 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-01 Option Award | 2026-04-03 1:40 pm | N/A 2036-03-31 | Metagenomi Therapeutics Inc. | MGX | Wapnick Pamela Chief Financial Officer | 168,000 | $0 | 355,375 (Direct) | View |
| 2025-12-01 Option Award | 2025-12-01 7:32 pm | N/A N/A | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 120,000 | $1.6 | 190,532 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 11:58 am | N/A 2035-03-31 | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 98,000 | $0 | 157,684 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:52 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 360,766 | $0 | 360,766 (Direct) | View |